First-line bevacizumab plus paclitaxel in Japanese patients...

  • Main
  • 2017 / 02
  • First-line bevacizumab plus paclitaxel in Japanese patients...
Japanese Journal of Clinical Oncology 2017 / 02

First-line bevacizumab plus paclitaxel in Japanese patients with HER2-negative metastatic breast cancer: subgroup results from the randomized Phase III MERiDiAN trial

Masuda, Norikazu, Takahashi, Masato, Nakagami, Kazuhiko, Okumura, Yasuhiro, Nakayama, Takahiro, Sato, Nobuaki, Kanatani, Kazumitsu, Tajima, Kosei, Kashiwaba, Masahiro
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Japanese Journal of Clinical Oncology
DOI:
10.1093/jjco/hyx001
Date:
February, 2017
File:
PDF, 401 KB
english, 2017
Conversion to is in progress
Conversion to is failed